ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0902

Novel Role of TYK2mechanism in SLE Pathogenesis via T Cell and B Cell Pathways

Joshua Hoffman1, Nicole Narayan2 and Mera Tilley1, 1Alumis Inc, South San Francisco, CA, 2Alumis, South San Francisco, CA

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, Bioinformatics, Genome Wide Association Studies, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Genetics, Genomics & Proteomics Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: SLE is a complex disease in need of novel therapies. Previously reported genome-wide association studies (GWAS) have identified a strong association between SLE and variants at the TYK2 locus, a well-known modulator of type 1 interferon and IL-12/23 signaling pathways. In this study we integrate SLE GWAS summary statistics and proteomics data from the UK Biobank resource to uncover additional pathways by which TYK2 modulates SLE pathogenesis. 

Methods: Summary statistics for a GWAS in SLE from the NHGRI-EBI GWAS Catalog were fine-mapped using susieR.  Fine-mapped variants were then subjected to a trans-protein-quantitative trait locus (pQTL) analysis using O-link data made available through UK Biobank. To assess whether TYK2 specific variants are uniquely driving signals in the region, we performed a GWAS on all proteins that were significant in the initial single-variant pQTL screen followed by fine-mapping and colocalization with the SLE GWAS summary statistics.  For pQTL associations that showed significant colocalization with SLE genetic susceptibility, we performed a protein level association analysis on SLE disease risk in UK Biobank. 

Results: Fine-mapping with the SLE GWAS resulted in two independent variant sets at the TYK2 locus, with one of those sets defined by the well-characterized TYK2 loss-of-kinase-function allele P1104A (rs34536443), a pharmacomimetic of TYK2 inhibition.  The initial pQTL screen identified 12 unique proteins as having at least one SLE based TYK2 variant association. Of these; IL12RB1, IFNAR1, BST2, CCL3, CCL4, CXCL10, CXCL11, LAG3, TNFRSF8, and TNFSF13B showed colocalization with SLE. Levels of these proteins were significantly increased in SLE cases compared to controls in the UK Biobank cohort. 

Conclusion: TYK2 genetic loss-of-kinase-function has previously been shown to be protective for a wide array of immune-mediated diseases. In this study, we aimed to uncover new protein pathways that may be influenced by TYK2 variation and furthermore contribute to SLE disease pathogenesis.  Novel T-cell and B-cell proteogenomic signatures were discovered to be mediated by TYK2 in the context of SLE. Two examples include LAG3 and TNFSF13B. LAG3 is a negative regulator of T-cell response; TNFSF13B is highly expressed in monocytes and acts in B-cell activation, differentiation, and proliferation. As a positive control, the results of our analyses corroborated the known association of TYK2 with IL12 and type 1 interferon pathways via modulation of IL12RB1 and IFNAR1 protein levels. Through systematic colocalization of trans-pQTL signals, we identified pathways beyond type I interferons that may contribute to the protective effect of TYK2 loss of function variants in autoimmune diseases.


Disclosures: J. Hoffman: Alumis Inc, 3, 11; N. Narayan: Alumis Inc, 3, 11; M. Tilley: Alumis Inc, 3, 11.

To cite this abstract in AMA style:

Hoffman J, Narayan N, Tilley M. Novel Role of TYK2mechanism in SLE Pathogenesis via T Cell and B Cell Pathways [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/novel-role-of-tyk2mechanism-in-sle-pathogenesis-via-t-cell-and-b-cell-pathways/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/novel-role-of-tyk2mechanism-in-sle-pathogenesis-via-t-cell-and-b-cell-pathways/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology